GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NewAmsterdam Pharma Co NV (FRA:KH6) » Definitions » Ending Cash Position

NewAmsterdam Pharma Co NV (FRA:KH6) Ending Cash Position : €-69.98 Mil (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is NewAmsterdam Pharma Co NV Ending Cash Position?

NewAmsterdam Pharma Co NV's Ending Cash Position for the quarter that ended in Dec. 2023 was €-69.98 Mil.

NewAmsterdam Pharma Co NV's quarterly Ending Cash Position declined from Dec. 2022 (€441.54 Mil) to Jun. 2023 (€384.67 Mil) and declined from Jun. 2023 (€384.67 Mil) to Dec. 2023 (€-69.98 Mil).

NewAmsterdam Pharma Co NV's annual Ending Cash Position increased from Dec. 2021 (€53.22 Mil) to Dec. 2022 (€441.54 Mil) but then declined from Dec. 2022 (€441.54 Mil) to Dec. 2023 (€312.19 Mil).

NewAmsterdam Pharma Co NV Ending Cash Position Historical Data

The historical data trend for NewAmsterdam Pharma Co NV's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NewAmsterdam Pharma Co NV Ending Cash Position Chart

NewAmsterdam Pharma Co NV Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Ending Cash Position
7.95 53.22 441.54 312.19

NewAmsterdam Pharma Co NV Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Ending Cash Position Get a 7-Day Free Trial 53.22 88.42 441.54 384.67 -69.98

NewAmsterdam Pharma Co NV Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

NewAmsterdam Pharma Co NV's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=428.907+-116.714
=312.19

NewAmsterdam Pharma Co NV's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=-8.1+-61.877
=-69.98

NewAmsterdam Pharma Co NV Ending Cash Position Related Terms

Thank you for viewing the detailed overview of NewAmsterdam Pharma Co NV's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

NewAmsterdam Pharma Co NV (FRA:KH6) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NewAmsterdam Pharma Co NV (FRA:KH6) » Definitions » Ending Cash Position
Comparable Companies
MDXG VERV AKRO ADMA ICPT SLNO INVA OLMA NVAX COGT OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
NAMS:USA KH6:Germany
Address
Gooimeer 2-35, Naarden, NH, NLD, 1411 DC
Website
https://www.newamsterdampharma.com
NewAmsterdam Pharma Co NV is a clinical-stage company focused on the research and development of transformative therapies for metabolic diseases and Alzheimer's disease.

NewAmsterdam Pharma Co NV (FRA:KH6) Headlines

No Headlines